Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]

U A Nitz¹, O Gluz², M Christgen³, E-M Grischke⁴, D Augustin⁵, S Kuemmel⁶, M Braun⁷, J Potenberg⁸, A Kohls⁹, K Krauss¹⁰, A Stefek¹¹, C Schumacher¹², H Forstbauer¹³, T Reimer¹⁴, H Fischer¹⁵, C Liedtke¹⁶, R Wuerstlein¹⁷, J Schumacher¹⁸, R Kates¹⁹, H Kreipe²⁰, N Harbeck²¹; West-German Study Group (WSG)-ADAPT Investigators

Affiliations

¹ West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany.
² West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany; University of Cologne, Cologne, Germany. Electronic address: oleg.gluz@wsg-online.com.
³ Institute of Pathology, Medical School Hannover, Hannover, Germany.
⁴ Department of Gynecology and Obstetrics, University Clinics Tuebingen, Tuebingen, Germany.
⁵ Breast Center Ostbayern, Deggendorf, Germany.
⁶ Breast Center, Clinics Essen-Mitte, Essen, Germany.
⁷ Rotkreuz Clinics Munich Breast Center, Munich, Germany.
⁸ Department of Oncology Evangelical Waldkrankenhaus Berlin, Berlin, Germany.
⁹ Department of Gynecology and Obstetrics, Evangelical Hospital, Ludwigsfelde, Germany.
¹⁰ Department of Gynecology and Obstetrics, University Clinics RWTH, Aachen, Germany.
¹¹ Breast Center, Evangelical Hospital Johanniter, Stendal, Germany.
¹² Breast Center, St. Elisabeth Hospital Cologne, Cologne, Germany.
¹³ Oncology Practice Network, Troisdorf, Germany.
¹⁴ Department of Gynecology and Obstetrics, University Clinics Rostock, Suedstadt, Germany.
¹⁵ Breast Center, Evangelical Hospital Gelsenkirchen, Gelsenkirchen, Germany.
¹⁶ Department of Gynecology and Obstetrics, University Clinics Schleswig-Holstein/Campus Luebeck, Luebeck, Germany; Charite Berlin, Germany.
¹⁷ Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.
¹⁸ Palleos Healthcare, Statistics, Wiesbaden, Germany.
¹⁹ West German Study Group GmbH, Moenchengladabach, Germany.
²⁰ University of Cologne, Cologne, Germany.
²¹ West German Study Group GmbH, Moenchengladabach, Germany; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.

PMID: 35012798
DOI: 10.1016/j.annonc.2021.12.008

Free article

Published Erratum

Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]

U A Nitz et al. Ann Oncol. 2022 Mar.

Free article

. 2022 Mar;33(3):355.

doi: 10.1016/j.annonc.2021.12.008. Epub 2022 Jan 7.

Authors

Affiliations

¹ West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany.
² West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany; University of Cologne, Cologne, Germany. Electronic address: oleg.gluz@wsg-online.com.
³ Institute of Pathology, Medical School Hannover, Hannover, Germany.
⁴ Department of Gynecology and Obstetrics, University Clinics Tuebingen, Tuebingen, Germany.
⁵ Breast Center Ostbayern, Deggendorf, Germany.
⁶ Breast Center, Clinics Essen-Mitte, Essen, Germany.
⁷ Rotkreuz Clinics Munich Breast Center, Munich, Germany.
⁸ Department of Oncology Evangelical Waldkrankenhaus Berlin, Berlin, Germany.
⁹ Department of Gynecology and Obstetrics, Evangelical Hospital, Ludwigsfelde, Germany.
¹⁰ Department of Gynecology and Obstetrics, University Clinics RWTH, Aachen, Germany.
¹¹ Breast Center, Evangelical Hospital Johanniter, Stendal, Germany.
¹² Breast Center, St. Elisabeth Hospital Cologne, Cologne, Germany.
¹³ Oncology Practice Network, Troisdorf, Germany.
¹⁴ Department of Gynecology and Obstetrics, University Clinics Rostock, Suedstadt, Germany.
¹⁵ Breast Center, Evangelical Hospital Gelsenkirchen, Gelsenkirchen, Germany.
¹⁶ Department of Gynecology and Obstetrics, University Clinics Schleswig-Holstein/Campus Luebeck, Luebeck, Germany; Charite Berlin, Germany.
¹⁷ Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.
¹⁸ Palleos Healthcare, Statistics, Wiesbaden, Germany.
¹⁹ West German Study Group GmbH, Moenchengladabach, Germany.
²⁰ University of Cologne, Cologne, Germany.
²¹ West German Study Group GmbH, Moenchengladabach, Germany; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.

PMID: 35012798
DOI: 10.1016/j.annonc.2021.12.008

No abstract available

PubMed Disclaimer

Erratum for

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel.
Nitz UA, Gluz O, Christgen M, Grischke EM, Augustin D, Kuemmel S, Braun M, Potenberg J, Kohls A, Krauss K, Stefek A, Schumacher C, Forstbauer H, Reimer T, Fischer H, Liedtke C, Wuerstlein R, Schumacher J, Kates R, Kreipe H, Harbeck N. Nitz UA, et al. Ann Oncol. 2017 Nov 1;28(11):2768-2772. doi: 10.1093/annonc/mdx494. Ann Oncol. 2017. PMID: 28945833 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Affiliations

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous